Distinct Expression Patterns of Osteopontin and Dentin Matrix Protein 1 Genes in Pituitary Gonadotrophs

Cell-matrix interactions play important roles in pituitary development, physiology, and pathogenesis. In other tissues, a family of non-collagenous proteins, termed SIBLINGs, are known to contribute to cell-matrix interactions. Anterior pituitary gland expresses two SIBLING genes, Dmp1 (dentin matrix protein-1) and Spp1 (secreted phosphoprotein-1) encoding DMP1 and osteopontin proteins, respectively, but their expression pattern and roles in pituitary functions have not been clarified. Here we provide novel evidence supporting the conclusion that Spp1/osteopontin, like Dmp1/DMP1, are expressed in gonadotrophs in a sex- and age-specific manner. Other anterior pituitary cell types do not express these genes. In contrast to Dmp1, Spp1 expression is higher in males; in females, the expression reaches the peak during the diestrus phase of estrous cycle. In further contrast to Dmp1 and marker genes for gonadotrophs, the expression of Spp1 is not regulated by gonadotropin-releasing hormone in vivo and in vitro. However, Spp1 expression increases progressively after pituitary cell dispersion in both female and male cultures. We may speculate that gonadotrophs signal to other pituitary cell types about changes in the structure of pituitary cell-matrix network by osteopontin, a function consistent with the role of this secretory protein in postnatal tissue remodeling, extracellular matrix reorganization after injury, and tumorigenesis.


INTRODUCTION
Cell-extracellular matrix (ECM) tridimensional network is critical for the proper functioning of all tissues (1), including anterior pituitary gland (2). Individual components of ECM include two main classes of macromolecules; proteoglycans and fibrous proteins (laminin, collagens, elastins, and fibronectin) (3,4). The effects of the ECM are mediated mainly by plasma membrane receptors called integrins; individual components of ECM bind to different integrins, leading to activation of multiple signaling pathways (5). In anterior pituitary, the presence of ECM molecules, like collagens, laminin, and small leucine-rich proteoglycans, and cell types producing these proteins have been identified (6)(7)(8)(9)(10). Pituitary cells also express integrins (11). There is increasing evidence that ECM is critical for development and differentiation of the pituitary gland (12), for postnatal cell migration and pituitary remodeling (13), and for hormone secretion (14,15). As in other tissues, ECM molecules may also have important roles in pituitary tumorigenesis (16).
In addition to proteoglycans and fibrous proteins, ECM contains other proteins, including SIBLINGs (Small Integrin-Binding Ligand, N-linked Glycophosphoproteins). SIBLINGs are encoded by a family of five genes, comprising secreted phosphoprotein 1 (Spp1), which encodes osteopontin (OPN), integrin-binding sialoprotein, which encodes bone sialoprotein, and dentin matrix protein 1 (Dmp1), dentin sialophosphoprotein and matrix extracellular phosphoglycoprotein, which encode proteins with the same name (17). SIBLINGs are soluble, secreted proteins that can act as modulators of cell adhesion as well as autocrine and paracrine ligands for ECM receptors. For example, OPN activates a variety of integrin receptors as well as CD44 receptor splice variants (18). The ligand activities of SIBLINGs are modulated by post-translational modifications, such as phosphorylation, glycosylation, proteolytic processing, sulphation, and transglutaminase cross-linking (19,20).
SIBLINGs were initially described as mineralized tissueassociated genes (21). However, recent findings indicate that they are more widely distributed, including normal ductal epithelia in salivary gland (22) and kidney (23). Spp1/OPN were also detected in central nervous system (24), where they may play a role in neurodegenerative diseases, such as Alzheimer's disease (25), Parkinson's disease (26), and multiple sclerosis (27,28). Dmp1/DMP1 was reported to be expressed in the brain, as well as in the liver, muscle, pancreas and kidney (29). SIBLING gene family is also expressed in various tumors (18,30) and OPN was suggested to be a valuable biomarker for diagnosing and treating cancers (31).
Our recent RNA-sequence analysis revealed that Dmp1 and Spp1, but no other SIBLING genes, were also expressed in anterior pituitary cells (32). The expression of Dmp1 is restricted to gonadotrophs, cells that produce luteinizing hormone (LH) and follicle-stimulating hormone (FSH), and is stimulated by gonadotropin-releasing hormone (GnRH) but not by other hypothalamic releasing factors. GnRH-induced expression of this gene is coupled with release of DMP1 in extracellular medium through the regulated secretory pathway. In vivo, the sex-specific pituitary Dmp1 expression is established during the peripubertal period and is elevated after ovulation. GnRH induction of Dmp1 is mediated by the protein kinase C signaling pathway through ERK1/2 signaling pathway; in addition, the response is facilitated by progesterone (32). It has also been shown that Spp1 is expressed in gonadotrophs and that mRNA levels were down regulated in anterior pituitary of lactating animals and by injection of estradiol (33).
Here we summarize work on Spp1 expression in rat anterior pituitary cells in vivo and in vitro. These include sexual dimorphism in Spp1 expression during maturation, effects of cell-matrix network destruction by cell dispersion procedure on Spp1 expression, and evaluation of the role of GnRH receptors (GnRHR) in the expression of this gene. We also studied the Abbreviations: DMP1, dentin matrix protein 1; ECM, extracellular matrix; FSH, follicle-stimulating hormone; GnRH, gonadotropin-releasing hormone; GnRHR, GnRH receptor; LH, luteinizing hormone; OPN, osteopontin; SIBLINGs, small integrin-binding ligand, N-linked glycophosphoproteins; Spp1, secreted phosphoprotein 1. expression pattern of OPN in prepubertal females and males and cycling females as well as the cell type specificity in expression of this protein. Finally, we compared Spp1 expression with Dmp1 expression in pituitary gonadotrophs.

Animals
Experiments were performed with female and male Sprague Dawley rats obtained from Taconic Farms (Germantown, NY). Animals were housed under constant conditions of temperature and humidity, with light on between 6 a.m. and 8 p.m. All experiments were repeated at least three times and were approved by the NICHD Animal Care and Use Committee (16-041).

Ontogeny of Spp1/OPN Expression
Experiments were performed with 2 days to 12 weeks old female and male rats. In some postpubertal females, a vaginal smear was taken of adult females to obtain information about the estrous cycle stage. Vaginal material was stained by a 0.1% aqueous solution of methylene blue and examined under a microscope. Animals were euthanized via asphyxiation with CO 2 and whole pituitary or anterior pituitary glands were removed and used for histological preparations or RNA extraction as described below.

Anterior Pituitary Cell Culture
For in vitro experiments, 4-or 7-week-old female and male rats were euthanized in the morning. After decapitation anterior pituitary glands were removed and pituitary cells were mechanically dispersed after trypsin and EDTA treatments as previously described (34). Dispersed cells were seeded on poly-D-lysine coated 24-well plates, 1.5 million per well. Plated cells were initially cultured in medium 199 containing Earle's salts, sodium bicarbonate, penicillin (100 units per ml), streptomycin (100 µg per ml) and 10% heat-inactivated horse serum (Life Technologies, Grand Island, NY). If not otherwise specified, experiments were performed with cells cultured overnight, washed and bathed in medium 199 with Hank's salt and containing 0.1% BSA. At the end of experiments, attached cells were scraped for RNA extraction.

In Vivo Treatments
Four-or seven-week-old female and male rats were injected once intraperitoneally with a GnRHR agonist, buserelin acetate (5 µg/0.4 ml/per animal) from Sigma (St. Louis, MO) or PBS (0.4 ml/per animal). Euthanasia was performed 3, 6, or 9 h after intraperitoneal injections. After decapitation, blood was collected, and serum was separated and stored at −80 • C for LH concentration measurement. The whole anterior pituitaries were collected in RNA later stabilization solution (Thermo Fisher Scientific, Waltham, MA) for RNA extraction.

qRT-PCR Analysis
Total RNA was extracted from individual anterior pituitary glands and primary cultures of anterior pituitary cells using RNeasy Plus Mini Kit (Qiagen, Valencia, CA). RNA was reverse transcribed with a Transcriptor First Stand cDNA Synthesis Kit (Roche Applied Sciences, Indianapolis, IN). Quantitative RT-PCR was performed using Applied Biosystems pre-designed Taq-Man Gene Expression Assays for rats using the LightCycler R TaqMan R Master Mix and the LightCycler 2.0 Real-time PCR system (Roche Applied Science). Target gene expression levels were determined by the comparative 2 ∧ (-delta C(T)) quantification method using Gapdh as the reference gene, which was previously established to be a suitable reference gene for the anterior pituitary tissue (35). Applied Biosystems predesigned TaqMan Gene Expression Assays were used: Dmp1: Rn01450122_m1, Spp1 (Rn00681031_m1), Gnrhr (Rn00578981_m1), and Gapdh: Rn01462662_g1.

Immunohistochemical Analysis
Whole pituitaries were quickly and carefully isolated and fixed in Bouin's solution for 48 h. Tissue was then embedded in paraffin and cut in coronal plane. Five µm thick sections were mounted on glass slides and processed for immunohistochemistry as previously described (36,37). Briefly, after deparaffinization, antigen retrieval in citrate buffer (0.01 M, pH 6) was performed. Monoclonal OPN antibody (The Developmental Studies Hybridoma Bank, Iowa City, IA) in 1:400 dilution was applied overnight at 4 • C. Secondary donkey anti-mouse-HRP (Santa Cruz Biotechnology, Dallas, TX) was then applied at 1:200 dilution for 2 h, and visualization was afterwards performed with diaminobenzidine tetrahydrochloride (Vector Laboratories, Burlingame, CA). Slides were mounted with DPX (Sigma, St. Louis, MO) and sections examined under an Olympus BX61 microscope. For double immunofluorescence studies, after incubation of sections with the OPN antibody, secondary Alexa Fluor donkey-anti-mouse 488 (Thermo Fisher Scientific, Waltham, MA) was applied at 1:400 dilution for 2 h. Sections were then incubated for 2 h with rabbit-anti rat LH or guinea pig-anti FSH (1:500 dilution) obtained from Dr. A. F. Parlow (National Institute of Diabetes and Digestive and Kidney Diseases, National Hormone and Peptide Program, Torrance, CA). Following the incubation with donkey-anti rabbit or donkey-anti guinea pig 555 Alexa Fluor secondary antibodies (1:400 dilution) slides were mounted with Mowiol based mounting medium and examined under inverted Zeiss LSM 510 confocal microscope. Triple immunofluorescence labeling was done as described above using Alexa Fluor Dyes: donkey-anti rabbit 488, donkey-anti guinea pig 555, and donkey-anti mouse 647 (Thermo Fisher Scientific, Waltham, MA), and the sections were examined under Leica TCS SP5 II confocal microscope.

Statistics
All numerical values in the text are reported as the mean ± SEM from one of at least three similar in vivo or in vitro experiments. KaleidaGraph Program (Synergy Software, Reading, Pennsylvania) was used for all calculation and graph presentation. Significant differences between means were determined by a Student's t-test or an ANOVA accompanied with the post hoc Student-Newman-Keuls test as well as for regression/correlation analyses and calculation of the half time of decay in gene expression. P-values of <0.05 were considered significant.

Spp1 Is Expressed in Anterior Pituitary of Developing Animals in a Sex-Specific Manner
The Spp1 expression was investigated in male and female anterior pituitary tissue from 2 days to 12 weeks old rats ( Figure 1A). During this period, the gene was expressed in both sexes and the mRNA expression varied between 5 and 70% of the expression of Gapdh, a housekeeping gene. Pituitaries obtained from animals up to 3 weeks of age showed no sex difference in the expression of Spp1. From week four onward, however, the sex-specific expression pattern was established. First, Spp1 levels were always significantly higher in male pituitaries. Second, there were differences in terms of timing needed to reach the peak in mRNA expression. In males, there was a progressive increase in Spp1 expression, reaching the peak value at 5 weeks of age, with ∼13-fold increase in expression when compared to the second day of age. This was followed by a progressive decrease in gene expression during peripubertal and postpubertal periods. In females, however, the first peak in expression was reached during infantile period, with an ∼3-fold increase compared to the second day of age. This was followed by a gradual decline during the juvenile, peripubertal and postpubertal age, with a secondary transient increase in expression at the age of 8 weeks ( Figure 1A).
In both female and male rats, the developmental profiles of Spp1 were highly comparable to profiles of major gonadotrophspecific (hereafter marker) genes, Gnrhr, Lhb, and Fshb, as well as to the gonadotroph/thyrotroph-specific gene Cga (35). This prompted us to examine the relationship between Spp1 expression vs. marker gene expression during sexual maturation. This was done using a linear correlation analysis and the Pearson r-coefficient as an indicator of significance of correlation. Scatter data points for Gnrhr vs. Spp1 in developing males ( Figure 1B) and females (Figure 1C), had a linear tendency, with the r value significant in both cases.
Furthermore, Spp1 expression correlated well with the expression of Lhb, Fshb, and Cga in males (Figures 2A-C). There was also correlation between Spp1 vs. Cga in females ( Figure 2F), with comparable r-coefficient values in females and males, as well as between Spp1 and Lhb expression ( Figure 2D), but with lower r-coefficient in females when compared with males. Finally, the r-coefficient value was not significant when Spp1 expression was compared with Fshb expression in females ( Figure 2E). The data points from prepubertal females (shown in gray) and in postpubertal females (shown in white) suggest that correlation was attenuated in postpubertal animals.
In contrast to gonadotroph marker genes, no correlation was observed between Spp1 expression vs. expression of Pomc, a marker gene for corticotrophs and melanotrophs, Tshb, a marker gene for thyrotrophs, Gh1, a marker gene for somatotrophs, and Prl, a marker gene for lactotrophs (data not shown).
These results suggest that Spp1 is expressed in pituitary gland in a sex-specific manner and that expression of this gene during development is synchronized with expression of gonadotroph signature genes, a finding consistent with a hypothesis that this gene is active only in gonadotrophs. However, the expression of Spp1 is regulated differently than the expression of gonadotroph marker genes during the estrous cycle.

In vivo OPN Is Specifically Expressed in Pituitary Gonadotrophs
To clarify this hypothesis, we performed an immunohistochemical analysis of pituitary tissue using antibodies specific for OPN, a protein encoded by Spp1, LHβ, and FSHβ. This analysis confirmed that OPN was also present in both female and male pituitary cells during sexual maturation. Figure 3 shows OPN-positive cells in female and male pituitaries from prepubertal animals, with more positive cells observed in male pituitaries. In parallel to mRNA expression, OPNpositive cells were also visible in peripubertal and postpubertal anterior pituitaries from both sexes and with greater number of labeled cells in male tissue sections (data not shown). Finally, double immunohistochemical labeling indicated that all OPNpositive cells in males and females were also LHβ positive, i.e., that Spp1/OPN are specifically expressed in LHβ-positive gonadotrophs (Figure 4). Finally, triple immunohistochemical labeling indicated that most of the OPN positive cells in males were positive for both LHβ and FSHβ (Figure 5).
However, OPN labeling was not visible in all gonadotrophs (Figures 4, 5), suggesting that in vivo expression of OPN was bellow detection by immunohistochemistry in a fraction of these cells. In parallel to Spp1 expression during estrous cycle ( Figure 2G), greater number of OPN-positive gonadotrophs could be observed in diestrus when compared to other stages of the estrous cycle. Furthermore, OPN-positive gonadotrophs were more intensely labeled in diestrus (Figure 6). Finally, the difference in the expression of gonadotroph marker genes and Spp1 during estrous cycle suggest that Spp1 expression was probably independent of the status of GnRH secretion.

Basal Spp1 Expression Is Upregulated in Cultured Pituitary Cells
Next, we investigated the expression of basal Spp1 in primary pituitary cell cultures. After cell dispersion, the Spp1 expression progressively increased as a function of time in both female and male pituitary cell cultures. The upregulation of Spp1 expression persisted over several days; Figure 7A illustrates the time course of upregulation of Spp1 expression during the first 3 days of culturing in medium 199 containing 10% horse serum. Similar growth profiles in Spp1 expression were observed in cells cultured in medium 199 containing fetal calf serum (data not shown). In cells cultured in serum-free and 0.1% BSAcontaining medium, the growth in gene expression was not abolished and the rate of expression was only slightly attenuated. For example, in cells from 7-week old females cultured overnight in horse-serum containing medium or 0.1% BSA-containing medium, the expression of Spp1 was 53.21 ± 2.52 and 43.88 ± 3.26, respectively. In contrast to Spp1, the expression of Gnrhr decreased progressively with culturing time [ Figure 7B and (38)]. This indicates that loss of pulsatile GnRH stimulation and tridimensional pituitary structure has opposite effect on expression of Spp1 and gonadotroph marker genes.
The Spp1 expression in pituitary cells cultured in poly-Dlysine coated wells for 48 h was 112 ± 24, while in collagencoated wells was 134 ± 36, both relative to Gapdh expression (n = 6). However, the rate in Spp1 expression decreased in female pituitary cells cultured in horse serum-and BSA-containing medium when media were replaced with fresh medium once or twice during 72 h incubation ( Figure 7C). In contrast, the decay in Gnrhr expression was not affected by washing procedure (Figure 7D). These observations are consistent with a hypothesis that an autocrine or paracrine factor, other than GnRH (39), stimulates Spp1 expression.

Spp1 mRNA Expression Is Not Regulated by GnRH
To evaluate effects of GnRH on Spp1 mRNA expression more directly, we performed two types of experiments, in vitro and in vivo.   The results of in vivo experiments with 4-week-old female and male rats were summarized in Figure 9. Animals were intraperitoneally injected with saline solution (solvent) or 5 µg of buserelin acetate, a GnRHR agonist. Animals were sacrificed 3, 6, and 9 h after injection, blood was collected for serum LH measurements and pituitary glands were removed for qRT-PCR analysis. LH measurements confirmed that stimulus secretion coupling was operative under these experimental conditions (data not shown). We also observed a progressive Dmp1 expression of comparable levels to those observed in cultured pituitary cells (Figure 9A). However, buserelin acetate treatment did not affect Spp1 expression (Figure 9B). We also performed two in vitro experiments using pituitary cells from 7-week-old female rats. In the first experiment, cells were cultured overnight in GnRH-free medium, and after that for 2-60 h in the presence and absence of 10 nM GnRH. Under these conditions, GnRH-induced expression of Dmp1 (Figure 10A, top), with kinetics comparable to that we reported earlier, with a peak in response observed after 6 h GnRH application, followed by a decay to levels that were on the edge of detection by qRT-PCR (32). The subsequent application of GnRH was inefficient, indicating that decay in Dmp1 expression is not due to degradation of GnRH but reflects desensitization of response (data not shown). In contrast, during 60 h of incubation, there was a progressive increase in Spp1 expression in both controls and 10 nM GnRH-treated cells, but no significant differences between treated and untreated cells at the same time points (Figure 10A, bottom).
In the second experiment, pituitary cells were initially cultured for 96 h without GnRH, followed by washing and addition of fresh medium supplemented with 10 nM GnRH. Under these conditions, we also observed a time-dependent induction of Dmp1 expression by GnRH (Figure 10B, top), indicating that GnRH-induced intracellular signaling and stimulus transcriptional coupling were still operative. However, the expression of Spp1 was comparable in all groups (Figure 10B, bottom). In vivo injected buserelin acetate to 7-week old females also stimulated Dmp1 expression and did not affect Spp1 expression ( Figure 10C).

DISCUSSION
The expression of OPN mRNA in pituitary gonadotrophs has been reported previously (33). Here we provide further evidence that Spp1 is expressed in gonadotrophs but not in other pituitary cell types. First, the developmental pattern of Spp1/OPN is sexspecific and comparable to that observed for Lhb, Fshb, and Gnrhr (35), the well-established marker genes for gonadotrophs (40). Second, there was no correlation between Spp1 vs. Gh1, Prl, Tshb, and Pomc, the marker genes for somatotrophs, lactotrophs,   thyrotrophs, and corticotrophs, respectively. Third, immunohistochemical analysis showed the expression of OPN only in LHβ-and LHβ/FSHβ-positive cells. Our recent single cell RNAsequence also showed the expression of Spp1 in gonadotrophs only (NCBI Sequence Read Archive accession SRP151788). Thus, Spp1 is an additional gonadotroph-specific gene.
The expression of gonadotroph-marker genes, such as Lhb, Fshb, and Gnrhr, is regulated by GnRH (41). Previously we also showed that pulsatile GnRH application facilitated expression of numerous genes, including Fshb, Cga, and Gnrhr, but not Spp1 (32). Here we show that both in vitro and in vivo activations of GnRHR were ineffective in induction of Spp1. We also show that Spp1 expression varies during estrous cycle, with the pattern not comparable to endogenous GnRH release. Activation of other G protein-coupled receptors expressed in gonadotrophs was also ineffective. In other tissues, the expression of OPN is up-regulated by numerous growth and differentiation factors, including transforming growth factor-β superfamily, bone morphogenic proteins, epidermal growth factors, platelet-derived growth factor, and inflammatory cytokines. Also, steroids, retinoic acid, glucocorticosteroids, and 1.25-dihydroxyvitamin D3 increase OPN expression (42). In our experiments, IGF, EGF, TGFβ1, and activin were ineffective.
We established previously that Dmp1 is a gonadotrophspecific gene within cells of anterior pituitary gland (32). However, the expression of these two SIBLING genes in gonadotrophs varies. Both genes are expressed in vivo in a sexspecific manner, but the expression of Spp1 was always higher in males and Dmp1 was always better expressed in females. In postpubertal females, the expression of Spp1 was largest during the diestrus stage of estrous cycle, whereas the expression of Dmp1 was most prominent during the late proestrus. In further contrast to Spp1, the expression of Dmp1 in vivo and in vitro was regulated by GnRHR; continuous GnRH application caused a transient stimulation of Dmp1 expression followed by prolonged desensitization. Thus, although Dmp1 is a sister gene of Spp1, it follows the expression pattern of Lhb, Fshb, and Gnrhr (32,41).
The role of pituitary gonadotrophs in reproduction is wellestablished. Work with expression of SIBLINGs in pituitary gland indicates that gonadotrophs may have an additional cell-type specific function in anterior pituitary gland. At the present time, this function is unknown. Based on functions of OPN and DMP1 in other tissues, we may speculate that these proteins contribute to the proper organization of the cell-ECM tridimensional network, the former in GnRHR-dependent manner and the latter in a GnRHR-independent manner. The work on development of pituitary gland has indicated that, at birth, the pituitary cell types are roughly organized into layers with gonadotrophs being the most ventral (43). However, by adulthood spatial organization of the cell types appears more random (44). It has also been proposed that layering of pituitary cell types at birth could be required to establish networks of specific cell types, rather than a relationship with the timing of cell cycle exit (45). Thus, it is reasonable to speculate the potential role of these proteins in postnatal organization of pituitary.
We also present evidence, for the first time, that Spp1 expression increased progressively after pituitary cell dispersion in both female and male cultures, reaching 30-40-fold increase in mRNA levels within 3 days. Such response suggests that OPN signals to other pituitary cell types for changes in cellmatrix network structure. Spp1 is also upregulated as early as 6 h after skin wounding and healing was altered in mice lacking a functional Spp1. This and some additional analyses led the authors to conclude that OPN has a role in tissue remodeling and during matrix reorganization after injury (46). In general, OPN has been shown to promote attachment and spreading of a variety of cell types through its glycine-arginine-glycine-aspartate-serine cell binding domain, i.e., OPN can be classified as an adhesive protein (47). Thus, OPN may represent an initial signal for reconstruction of tridimensional structure of pituitary gland.
Consistent with this hypothesis, it has been shown that rat anterior pituitary cells in vitro can partly reconstruct the topographic nature of the pituitary gland, which includes few junctional complexes between hormone-producing cells (48). More recently, the same group reported about reassembly of anterior pituitary organization by hanging drop cell culture. Specifically, the authors reported that the topographic affinities of hormone-producing cells were maintained, that folliculostellate cells were interconnected with typical cytoplasmic protrusions to form tridimensional network, with the major ECM components, collagens and laminin, being deposited and distributed around the cells (49). It has also been reported that gonadotrophs can signal to the lactotrophs through the release of a paracrine humoral factor distinct from LH and FSH and in a GnRHindependent manner (50). Further studies indicated that a common alpha subunit of pituitary gonadotropins accounts for influence of gonadotrophs on lactotroph functions (51)(52)(53). We may speculate that OPN is another protein released by gonadotrophs, which contributes to the crosstalk among anterior pituitary cells.
Dispersion of pituitary cells could be considered as the stress situation for pituitary tissue. In general, OPN plays a role in immune regulation and stress responses (54). It has also a role in mediating oxidative stress (55), mechanical stress (56), and cellular stress (57). OPN also plays a significant role in the regulation of the hypothalamus-pituitary-adrenal axis hormones in animals exposed to chronic restraint stress (58). Cancer also reflects the loss of tissue organization and aberrant behavior of the cellular components and tumors have been likened to wounds that fail to heal (4). Not surprising, elevated OPN expression has been detected in numerous tumors (59)(60)(61). Elevated OPN levels were also detected in silent corticotroph adenomas and non-functioning gonadotroph adenomas (62). OPN expression is inhibitable on the levels of gene transcription and the RNA message, and its protein ligand activity can be blocked with antibodies or synthetic peptides, which led to idea to consider OPN as a candidate target for cancer therapy (63).
For understanding the signaling function of OPN in intact pituitary gland, dispersed pituitary cells, and pituitary tumors, it is critical to identify OPN receptors and cell types expressing these receptors. In general, OPN binds to several integrins, including αv(β1, β3, or β5), and (α4, α5, α8, or α9)β1, and is a ligand for CD44 receptor splice variants, specifically v6 and/or v7 possibly in conjunction with a β1 integrin (63). It is also known that exogenous addition of OPN to OPN-/-osteoclasts increased the surface expression of CD44 (64). The expression of αvβ3 integrin was reported in immortalized GH 3 lacto-somatotrophs (65). It has also been reported that cultured rat anterior pituitary cells expressed the β1 integrin subunit (11) as well as that integrin β1 signaling is required for the proliferation of folliculostellate cells in rat anterior pituitary gland under the influence of ECM (66). To our best knowledge, at the present time no data exist describing the expression of Cd44 and its protein in normal mammalian anterior pituitary cells.
In summary, here we provide further evidence for the expression of Spp1 and Dmp1 in pituitary gonadotrophs, but not other pituitary cell types, in an age-, sex-, and estrous cycle stage-specific manner. Two genes also differ in regulation of their expression; Dmp1 expression is regulated by GnRH, whereas Spp1 expression increases progressively in culturing pituitary cells in a GnRH-independent manner, presumably in response to an unidentified paracrine factor. Further work should be focused on secretion of these two proteins by gonadotrophs under different experimental paradigms, characterization of integrin and CD44 receptors within the secretory and non-secretory anterior pituitary cells and their signaling pathways, and function in pituitary gland.